Location: Dorado, Puerto Rico
CIK: 0001910456 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 13, 2025
Total Value: $491M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 1,534,141 | $144M | 29.4% | $36.34 | — | COM | N5749R100 |
| STOK | STOKE THERAPEUTICS INC | 5,404,674 | $110M | 22.4% | $8.00 | +114.3% | COM | 86150R107 |
| GHRS | GH RESEARCH PLC | 8,601,189 | $104M | 21.2% | $10.57 | +32.3% | ORDINARY SHARES | G3855L106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 700,014 | $46.5M | 9.5% | $41.90 | +35.6% | COM | 74366E102 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,766,090 | $34.19M | 7.0% | $10.25 | -28.6% | COM | 230031106 |
| CCCC | C4 THERAPEUTICS INC | 7,098,133 | $15.76M | 3.2% | $4.48 | -46.4% | COM STK | 12529R107 |
| TCRX | TSCAN THERAPEUTICS INC | 7,857,347 | $14.3M | 2.9% | $2.32 | -23.6% | COM | 89854M101 |
| DTIL | PRECISION BIOSCIENCES INC | 1,042,596 | $5.755M | 1.2% | $6.69 | -28.4% | COM NEW | 74019P207 |
| ADCT | ADC THERAPEUTICS SA | 1,325,848 | $5.303M | 1.1% | $3.15 | 0.0% | SHS | H0036K147 |
| PASG | PASSAGE BIO INC | 623,704 | $5.008M | 1.0% | $6.96 | 0.0% | COM NEW | 702712209 |
| DNLI | DENALI THERAPEUTICS INC | 261,687 | $3.8M | 0.8% | $14.37 | 0.0% | COM | 24823R105 |
| IBIO | IBIO INC | 1,055,897 | $874K | 0.2% | $1.47 | -47.8% | COM NEW | 451033708 |
| ALLO | ALLOGENE THERAPEUTICS INC | 546,119 | $677K | 0.1% | $2.63 | -54.6% | COM | 019770106 |
| DSGN | DESIGN THERAPEUTICS INC | 65,954 | $497K | 0.1% | $4.77 | +5.0% | COM | 25056L103 |